HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The case against mandatory newborn screening for HIV antibodies.

Abstract
The paper examines the controversy surrounding legislative proposals in New York State that would require amending the public health law's stringent confidentiality provisions; the legislation calls for "unblinding" the results of a 7-year old statewide HIV seroprevalence study that tests newborns for HIV antibodies in order to track the incidence of HIV infection among parturient women. The pivotal point is made that mandatory disclosure of the test results is tantamount to mandatory testing of the mother, since presence (or absence) of HIV antibodies conclusively reveals the mother's HIV status. The author presents the history of the epidemiological study and documents the ongoing discussion of mandatory testing, within the medical, bioethical and public health community. Citing numerous papers, including the report of the Subcommittee on Newborn Screening of the New York State AIDS Advisory Council, the author--a member of both the council and its subcommittee--argues against the principle of mandatory testing in general and "unblinding" of the seroprevalence survey in particular. Besides making a strong argument from the ethical viewpoint, the paper provides ample medical data to support the argument that mandatory testing of newborns is poor public health policy that would be essentially ineffectual in the effort to stem the spread of HIV.
AuthorsA O Dumois
JournalJournal of community health (J Community Health) Vol. 20 Issue 2 Pg. 143-59 (Apr 1995) ISSN: 0094-5145 [Print] Netherlands
PMID7642780 (Publication Type: Journal Article)
Topics
  • Advisory Committees
  • Anonymous Testing
  • Civil Rights
  • Confidentiality
  • Contact Tracing (legislation & jurisprudence)
  • Disclosure
  • Disease Notification (legislation & jurisprudence, methods)
  • Female
  • HIV Infections (epidemiology, prevention & control, transmission)
  • Health Planning Councils
  • Health Planning Guidelines
  • Health Policy (legislation & jurisprudence)
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Mothers
  • Neonatal Screening (legislation & jurisprudence)
  • New York (epidemiology)
  • Pregnancy
  • Risk Assessment
  • Voluntary Programs
  • Women's Rights

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: